Stock Analysis

First Sponsor Group Full Year 2024 Earnings: EPS: S$0.083 (vs S$0.013 in FY 2023)

SGX:ADN
Source: Shutterstock
Advertisement

First Sponsor Group (SGX:ADN) Full Year 2024 Results

Key Financial Results

  • Revenue: S$317.6m (up 12% from FY 2023).
  • Net income: S$93.0m (up by S$80.5m from FY 2023).
  • Profit margin: 29% (up from 4.4% in FY 2023). The increase in margin was primarily driven by lower expenses.
  • EPS: S$0.083 (up from S$0.013 in FY 2023).
revenue-and-expenses-breakdown
SGX:ADN Revenue and Expenses Breakdown April 7th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Hotel Operations segment contributing a total revenue of S$187.2m (59% of total revenue). Notably, cost of sales worth S$181.7m amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to S$51.6m (120% of total expenses). Explore how ADN's revenue and expenses shape its earnings.

First Sponsor Group's share price is broadly unchanged from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with First Sponsor Group (at least 2 which are a bit concerning) , and understanding these should be part of your investment process.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SGX:ADN

First Sponsor Group

An investment holding company, invests in, develops, and sells residential and commercial properties in the People’s Republic of China, Europe, and internationally.

Proven track record average dividend payer.

Advertisement